Quest Diagnostics
DGX
#1086
Rank
A$27.02 B
Marketcap
$242.09
Share price
2.03%
Change (1 day)
15.94%
Change (1 year)
Quest Diagnostics is an American clinical laboratory company offering access to diagnostic testing services for cancer, cardiovascular disease, infectious disease, neurological disorders and employment and court ordered drug testing.

Revenue for Quest Diagnostics (DGX)

Revenue in 2024 (TTM): A$14.16 Billion

According to Quest Diagnostics 's latest financial reports the company's current revenue (TTM ) is A$14.49 Billion. In 2023 the company made a revenue of A$13.57 Billion a decrease over the revenue in the year 2022 that were of A$14.52 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Quest Diagnostics from 1997 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) A$14.16 B4.32%
2023 A$13.57 B-6.49%
2022 A$14.52 B-2.4%
2021 A$14.88 B21.25%
2020 A$12.27 B11.22%
2019 A$11.03 B3.22%
2018 A$10.69 B11.68%
2017 A$9.57 B-8.19%
2016 A$10.42 B1.36%
2015 A$10.28 B13.22%
2014 A$9.08 B13.39%
2013 A$8.01 B14.11%
2012 A$7.02 B-4.14%
2011 A$7.32 B0.97%
2010 A$7.25 B-12.59%
2009 A$8.29 B-19.23%
2008 A$10.27 B33.98%
2007 A$7.66 B-3.56%
2006 A$7.95 B5.93%
2005 A$7.50 B13.32%
2004 A$6.62 B3.93%
2003 A$6.37 B-12.58%
2002 A$7.29 B2.58%
2001 A$7.10 B16.17%
2000 A$6.11 B82.34%
1999 A$3.35 B40.87%
1998 A$2.38 B1.53%
1997 A$2.34 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
A$19.31 B 33.27%๐Ÿ‡บ๐Ÿ‡ธ USA
A$31.57 M-99.78%๐Ÿ‡บ๐Ÿ‡ธ USA
A$0.95 B-93.41%๐Ÿ‡บ๐Ÿ‡ธ USA
A$48.46 M-99.67%๐Ÿ‡บ๐Ÿ‡ธ USA
A$0.34 B-97.64%๐Ÿ‡บ๐Ÿ‡ธ USA
A$2.94 B-79.66%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands